FASPX | VMVAX | FASPX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 38 years | 13 years | - |
Gain YTD | 12.817 | 17.355 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.15B | 30.9B | 7% |
Annual Yield % from dividends | 0.24 | 2.14 | 11% |
Returns for 1 year | 22.54 | 27.09 | 83% |
Returns for 3 years | 12.89 | 13.54 | 95% |
Returns for 5 years | 57.18 | 47.45 | 120% |
Returns for 10 years | 37.09 | 96.84 | 38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSVRX | 11.45 | N/A | N/A |
Clifford Capital Fcs Sm Cp Val Inv | |||
TFGRX | 43.18 | -0.43 | -0.99% |
Touchstone Mid Cap Growth R6 | |||
GSRFX | 13.89 | -0.17 | -1.21% |
Goldman Sachs Rising Dividend Gr R6 | |||
JHJIX | 25.37 | -0.36 | -1.40% |
JHancock ESG Large Cap Core I | |||
JNGLX | 74.22 | -2.12 | -2.78% |
Janus Henderson Global Life Sciences D |